Influence of Propylthiouracil and Methimazole Pre-treatment on the Outcome of Iodine-131 Therapy in Hyperthyroid Patients with Graves' Disease

被引：8
|
作者：
Shi, G-M [1 ]
Xu, Q. [2 ]
Zhu, C-Y [2 ]
Yang, Y-L [2 ]
机构：
[1] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Chemotherapy, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Nucl Med, Hangzhou 310003, Zhejiang, Peoples R China
来源：
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 2009年 / 37卷 / 02期
关键词：
GRAVES' DISEASE; HYPERTHYROIDISM; PROPYLTHIOURACIL; METHIMAZOLE; (131)I THERAPY; RADIOACTIVE IODINE THERAPY; RANDOMIZED CLINICAL-TRIAL; RADIOIODINE THERAPY; ANTITHYROID DRUGS; CURE RATES; EFFICACY;
D O I：
10.1177/147323000903700235
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
There is ongoing controversy about potential differences in the influence of the anti-thyroid drugs propylthiouracil (PTU) and methimazole (MMI) on radioiodine treatment of Graves' hyperthyroidism. This retrospective study investigated the influence of PTU and MMI pre-treatment, individually or sequentially, on the outcome of iodine-131 ((131)I) therapy in 199 patients with Graves' disease who had been treated with (131)I for the first time and followed up at 3 and 6 months after treatment. Pre-treatment with PTU, or sequential PTU and MMI pretreatment, increased the failure rate of (131)I therapy and reduced the rate of hypothyroidism. MMI pre-treatment alone had no significant influence on the results of (131)I therapy. Logistic regression analyses indicated that PTU pre-treatment and having a thyroid gland of > 60 g were both significantly related to (131)I therapy failure.
引用
收藏
页码：576 / 582
页数：7
相关论文
共 50 条
  • [21] Determination of administered activities for the treatment of Graves' disease with iodine-131: Proposition of a simplified dosimetric procedure
    Soli, Idrissa Adamou
    Issoufou, Djibrillou Moussa
    Rahabi, Skander
    Ali, Ada
    Adehossi, Eric
    Bouyoucef, Salah Eddine
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2021, 20 (03) : 222 - 227
  • [22] IODINE PERCHLORATE DISCHARGE TEST BEFORE AND AFTER ONE-YEAR OF METHIMAZOLE TREATMENT OF HYPERTHYROID GRAVES-DISEASE
    ROTI, E
    MINELLI, R
    GARDINI, E
    BIANCONI, L
    SALVI, M
    GAVARUZZI, G
    UGOLOTTI, G
    BRAVERMAN, LE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (03): : 795 - 799
  • [23] The outcome of patients with relapsed or refractory Graves' disease and hyperfunctioning uni- or multinodular goiter after a personalized dose of Iodine-131
    Florimonte, L.
    Butti, I.
    Pagani, L.
    Di Leo, C.
    Maffioli, L. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S334 - S334
  • [24] Management of hyperthyroid patients following radioactive iodine therapy, with a specific emphasis on Graves' disease
    Taieb, D.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2020, 44 (04): : 284 - 286
  • [25] Influence of methimazole treatment on parameters of oxidative stress in patients with Graves' disease
    Gerenova J.
    Gadjeva V.
    Comparative Clinical Pathology, 2006, 15 (1) : 49 - 54
  • [26] The efficacy of melatonin against radiotoxicity of iodine-131 and its response to treatment in hyperthyroid patients: a randomized controlled trial
    Alidadi, Soudabe
    Monfared, Ali Shabestani
    Amiri, Mehrangiz
    Zabihi, Ebrahim
    Assadollahi, Ehsan
    Gholami, Amir
    Moazezi, Zoleika
    Abedian, Zeinab
    NUCLEAR MEDICINE REVIEW, 2022, 25 (01) : 31 - 36
  • [27] METHIMAZOLE, BUT NOT BETAMETHASONE, PREVENTS I-131 TREATMENT-INDUCED RISES IN THYROTROPIN RECEPTOR AUTOANTIBODIES IN HYPERTHYROID GRAVES-DISEASE
    GAMSTEDT, A
    WADMAN, B
    KARLSSON, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (04): : 773 - 777
  • [28] The preliminary clinical observation and analysis of childbearing-age women with a history of iodine-131 treatment for Graves' disease
    Guan, Liang
    Chen, Gang
    Zhang, Jiali
    Wang, Ling
    BIOSCIENCE TRENDS, 2016, 10 (04) : 307 - 314
  • [29] Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma
    Muratet, JP
    Daver, A
    Minier, JF
    Larra, F
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (09) : 1546 - 1550
  • [30] Radioactive Iodine Therapy of Graves' Disease in Patients Pretreated With Methimazole Without Radioiodine Uptake for Dose Estimation
    Mihailescu, Dan, V
    Hoscheit, Christine
    Fogelfeld, Leon
    ENDOCRINE PRACTICE, 2024, 30 (04) : 333 - 339
12345